Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)

China flag China · Delayed Price · Currency is CNY
13.70
+0.48 (3.63%)
Apr 30, 2026, 3:04 PM CST
-4.46%
Market Cap 3.96B
Revenue (ttm) 783.17M
Net Income (ttm) 22.49M
Shares Out 289.15M
EPS (ttm) 0.08
PE Ratio 176.32
Forward PE n/a
Dividend 0.10 (0.76%)
Ex-Dividend Date Jul 9, 2025
Volume 17,824,863
Average Volume 6,836,041
Open 13.12
Previous Close 13.22
Day's Range 13.12 - 14.09
52-Week Range 10.61 - 32.14
Beta 0.61
RSI 51.95
Earnings Date Apr 17, 2026

About SHE:002365

Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces ethylene oxide, polycarboxylic acid-based water reducer monomers, water reducers, and health products. The company engages in scientific research and technical service, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmaceutical Co., Ltd. was founded in 2001 and is based in Qianjiang, China. [Read more]

Sector Healthcare
Founded 2001
Employees 930
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002365
Full Company Profile

Financial Performance

In 2025, SHE:002365's revenue was 783.17 million, a decrease of -6.63% compared to the previous year's 838.81 million. Earnings were 22.49 million, a decrease of -63.58%.

Financial Statements

News

There is no news available yet.